NHERF1 and colorectal carcinoma: Interestingly, RS5517 alone did not confer any proliferative advantage to CRC cells compared with shRNA-based NHERF1 knockdown (Supplementary Figure S2), while promoting the outgrowth of more cohesive cell colonies in soft agar (Fig. 7d).